Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Carcinoma, Non-Sm september 22, 2023 Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Carcinoma, Non-Sm Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Carcinoma, Non-Small-Cell Lung;Thyroid Neoplasms, Date of authorisation: 11/02/2021, Revision: 8, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief. Delen Link ophalen Facebook Twitter Pinterest E-mail Andere apps Delen Link ophalen Facebook Twitter Pinterest E-mail Andere apps